Literature DB >> 24632843

Excretion of [3H]triptolide and its metabolites in rats after oral administration.

Jia Liu1, Xin Zhou1, Xiao-yan Chen1, Da-fang Zhong1.   

Abstract

AIM: To investigate the routes of elimination and excretion for triptolide recovered in rats.
METHODS: After a single oral administration of [(3)H]triptolide (0.8 mg/kg, 100 μCi/kg) in Sprague Dawley rats, urine and fecal samples were collected for 168 h. To study biliary excretion, bile samples were collected for 24 h through bile duct cannulation. Radioactivity was measured using a liquid scintillation analyzer, and excretion pathway analysis was performed using an HPLC/on-line radioactivity detector.
RESULTS: The total radioactivity recovered from the urine and feces of rats without bile duct ligation ranged from 86.6%-89.1%. Most of the radioactivity (68.6%-72.0%) was recovered in the feces within 72 h after oral administration, while the radioactivity recovered in the urine and bile was 17.1%-18.0% and 39.0%-39.4%, respectively. The HPLC/on-line radiochromatographic analysis revealed that most of the drug-related radioactivity was in the form of metabolites. In addition, significant gender differences in the quantity of these metabolites were found: monohydroxytriptolide sulfates were the major metabolites detected in the urine, feces, and bile of female rats, while only traces of these metabolites were found in male rats.
CONCLUSION: Radiolabeled triptolide is mainly secreted in bile and eliminated in feces. The absorbed radioactivity is primarily eliminated in the form of metabolites, and significant gender differences are observed in the quantity of recovered metabolites, which are likely caused by the gender-specific expression of sulfotransferases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24632843      PMCID: PMC4813726          DOI: 10.1038/aps.2013.192

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  18 in total

1.  Triptolide promotes generation of FoxP3+ T regulatory cells in rats.

Authors:  Gutian Zhang; Yong Liu; Hongqian Guo; Zeyu Sun; Yi-Hua Zhou
Journal:  J Ethnopharmacol       Date:  2009-06-26       Impact factor: 4.360

Review 2.  The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F.

Authors:  X Tao; P E Lipsky
Journal:  Rheum Dis Clin North Am       Date:  2000-02       Impact factor: 2.670

Review 3.  Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F.

Authors:  B J Chen
Journal:  Leuk Lymphoma       Date:  2001-07

4.  Pharmacokinetic study of triptolide, a constituent of immunosuppressive chinese herb medicine, in rats.

Authors:  Feng Shao; Guangji Wang; Haitang Xie; Xiaoyan Zhu; Jianguo Sun; Jiye A
Journal:  Biol Pharm Bull       Date:  2007-04       Impact factor: 2.233

5.  The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle.

Authors:  Zhinan Mei; Xiaokuan Li; Qunrong Wu; Sheng Hu; Xiangliang Yang
Journal:  Pharmacol Res       Date:  2005-04       Impact factor: 7.658

6.  Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF-kappaB and JNK in LPS-treated microglia.

Authors:  Yuntao Gong; Bing Xue; Jian Jiao; Liming Jing; Xiaomin Wang
Journal:  J Neurochem       Date:  2008-08-30       Impact factor: 5.372

7.  Enzymatic sulfation of steroids: I. The enzymatic basis for the sex difference in cortisol sulfation by rat liver preparations.

Authors:  S S Singer; D Giera; J Johnson; S Sylvester
Journal:  Endocrinology       Date:  1976-04       Impact factor: 4.736

8.  Natural product triptolide mediates cancer cell death by triggering CDK7-dependent degradation of RNA polymerase II.

Authors:  Stefano Giustino Manzo; Zhao-Li Zhou; Ying-Qing Wang; Jessica Marinello; Jin-Xue He; Yuan-Chao Li; Jian Ding; Giovanni Capranico; Ze-Hong Miao
Journal:  Cancer Res       Date:  2012-08-27       Impact factor: 12.701

9.  Male reproductive toxicity and toxicokinetics of triptolide in rats.

Authors:  Bin Ni; Zhenzhou Jiang; Xin Huang; Fengguo Xu; Rui Zhang; Zunjian Zhang; Yuan Tian; Tao Wang; Tian Zhu; Jing Liu; Luyong Zhang
Journal:  Arzneimittelforschung       Date:  2008

10.  Sex differences in sulfation and glucuronidation of phenol, 4-nitrophenol and N-hydroxy-2-acetylaminofluorene in the rat in vivo.

Authors:  J H Meerman; C Nijland; G J Mulder
Journal:  Biochem Pharmacol       Date:  1987-08-15       Impact factor: 5.858

View more
  6 in total

1.  CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats.

Authors:  Ye Xu; Yi-Fan Zhang; Xiao-Yan Chen; Da-Fang Zhong
Journal:  Acta Pharmacol Sin       Date:  2017-12-28       Impact factor: 6.150

2.  Inhibition of P-glycoprotein Gene Expression and Function Enhances Triptolide-induced Hepatotoxicity in Mice.

Authors:  Ling-Lei Kong; Xiao-Mei Zhuang; Hai-Ying Yang; Mei Yuan; Liang Xu; Hua Li
Journal:  Sci Rep       Date:  2015-07-02       Impact factor: 4.379

Review 3.  The molecular pathogenesis of triptolide-induced hepatotoxicity.

Authors:  Yeqing Hu; Qiguo Wu; Yulin Wang; Haibo Zhang; Xueying Liu; Hua Zhou; Tao Yang
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

Review 4.  Regulation of dietary polyphenols on cancer cell pyroptosis and the tumor immune microenvironment.

Authors:  Xiaoxia Huang; Yao Wang; Wenhui Yang; Jing Dong; Lin Li
Journal:  Front Nutr       Date:  2022-08-25

5.  Sex-Related Differences of Lipid Metabolism Induced by Triptolide: The Possible Role of the LXRα/SREBP-1 Signaling Pathway.

Authors:  Zhenzhou Jiang; Xiao Huang; Shan Huang; Hongli Guo; Lu Wang; Xiaojiaoyang Li; Xin Huang; Tao Wang; Luyong Zhang; Lixin Sun
Journal:  Front Pharmacol       Date:  2016-03-31       Impact factor: 5.810

6.  Mechanisms of Triptolide-Induced Hepatotoxicity and Protective Effect of Combined Use of Isoliquiritigenin: Possible Roles of Nrf2 and Hepatic Transporters.

Authors:  Zhenyan Hou; Lei Chen; Pingfei Fang; Hualin Cai; Huaibo Tang; Yongbo Peng; Yang Deng; Lingjuan Cao; Huande Li; Bikui Zhang; Miao Yan
Journal:  Front Pharmacol       Date:  2018-03-16       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.